Ariz. Admin. Code § R4-7-602 - Percutaneous Therapy as Applied to Chiropractic

A. "Percutaneous Therapy" means a skilled procedure performed by a Chiropractic Physician that uses a filiform needle to penetrate the skin and produce changes to underlying neural, muscular and other biologic tissues for the evaluation and management of neuromus-culoskeletal conditions.

B. "Percutaneous Therapy" includes the use of electrified needles.

C. Effective January 1, 2018, A Chiropractic Physician, who wishes to perform the Percutaneous Therapy procedure, shall have met the qualifications established in paragraph (D) before providing "Percutaneous Therapy."

D. A Chiropractic Physician offering to provide or providing "Percutaneous Therapy" procedure(s) shall provide documented proof of compliance with the qualifications to the Board within 30 days of completion of the course content in paragraph (G - J) or within 30 days of initial licensure as a chiropractic physician in Arizona.

E. An application for review and approval of a chiropractic physician offering to provide "Percutaneous Therapy" shall be made on a form and in a matter prescribed by the Board. An applicant shall pay the Board a non-refundable $50 fee for each application package.

F. An application for approval of a "Percutaneous Therapy" course shall comply with R4-7-801(E).

G. The course content shall be approved by one or more of the following entities prior to the course(s) being completed by the Chiropractic Physician.

1. State of Arizona Board of Chiropractic Examiners

2. American Chiropractic Association

3. The Federation of Chiropractic Licensing Boards

4. International Chiropractic Association

5. Providers of Approved Continuing Education (PACE)

6. American Medical Association

7. American Osteopathic Association

8. Accreditation Council for Continuing Medical Education (ACCME)

H. The course content shall include the following components of education and training:

1. Sterile Needle procedures to include either the U.S. Centers for Disease Control and Prevention, or The U.S. Occupational Safety and Health Administration

2. Anatomical Review

3. Blood Borne Pathogens

4. Indications and Contraindication for "Percutaneous Therapy"

L. The course content required of this section shall total a minimum of 24 in person contact hours of education.

J. At the request of a licensee, the Board may:

1. Review coursework completed prior to January 1, 2018 for approval.

2. Waive some or all of the hours required by subsection 4, if the licensee presents satisfactory proof of completing course work that constitutes adequate training of "Percutaneous Therapy" or of the components of education and training require for "Percutaneous Therapy".

3. Determine the licensee has received adequate training to be eligible to perform "Percutaneous Therapy."

4. Determine that a licensee who has been issued an Acupuncture certification is qualified to perform "Percutaneous Therapy".

K. The Standard of Care of the "Percutaneous Therapy" procedure includes, but is not limited to the Following:

1. "Percutaneous Therapy" cannot be delegated to any assistive personnel.

2. Consent & Documentation for Treatment shall be maintained in accordance with R4-7-101(1) and R4-7-902(5) & (6).

L. The Board may upon its own motion or on receipt of a complaint may withdraw its approval for a licensee to provide "Percutaneous Therapy" or it may withdraw its approval of a "Percutaneous Therapy" course.

M. The Board shall keep a register of licensees who have been approved to provide "Percutaneous Therapy".

Notes

Ariz. Admin. Code § R4-7-602

Repealed effective December 31, 1975 (Supp. 75-2). New Section R4-7-41 adopted effective January 25, 1984 (Supp. 84-1). Former Section R4-7-41 renumbered as Section R4-7-602without change effective September 27, 1985 (Supp. 85-5). Repealed effective December 9, 1994 (Supp. 94-4). Amended by final rulemaking at 23 A.A.R. 3534, effective 1/1/2018.